(Press-News.org) Quantum technologies from ultrasensitive sensors to next-generation information processors depend on the ability of quantum bits, or qubits, to maintain their delicate quantum states for a sufficiently long time to be useful.
One of the most important measures of this stability is the spin coherence time. Unfortunately, qubits may lose coherence because their environment is “noisy,” for example, due to the presence of nuclear isotopes or other interference that disturbs the qubit.
Two-dimensional (2D) materials—or atomically thin sheets—can offer quiet environments for qubits, as their reduced thickness naturally lowers the number of isotopes that interact with the qubit.
In a paper recently published by npj 2D Materials and Applications, researchers from the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) have created a high-throughput computational strategy, creating a new, data-driven approach to finding ideal 2D materials and substrates.
“With only a few 2D materials explored so far as qubit hosts, the field has lacked a comprehensive roadmap to identify new candidates, especially since 2D materials must be placed on a supporting substrate in realistic devices,” said first author Michael Toriyama, a postdoctoral researcher in UChicago PME’s Galli Group.
The new paper outlines a novel computational strategy to predict qubit coherence times across thousands of 2D materials interfaced with substrates. Using an automated framework built on the “cluster correlation expansion” method—a powerful way to simulate how isotopes interact with a qubit—the team calculated spin coherence times for more than one thousand monolayers, discovering 189 that could potentially support coherence times longer than those of diamond, a popular host of spin qubits.
“We found that materials such as WS2 and several Au-oxyselenides appear to be particularly promising, showing predicted coherence times in the tens of milliseconds—exceptional values for solid-state systems,” said UChicago PME Prof. Giulia Galli, senior author of the study.
These compounds share two common features: They contain very few nuclei with strong magnetic moments and many of their atoms naturally occur in spin-free isotopes.
“Their structural motifs, such as square-planar transition-metal–oxygen units, may also lend themselves to hosting qubits with desirable electronic properties,” said co-author Jiawei Zhan, a UChicago PME PhD candidate who performed several electronic structure calculations of the promising materials.
But qubits do not live in free-floating monolayers. They sit on substrates. The team therefore evaluated more than 1,500 2D material-substrate combinations, revealing that substrates can significantly degrade coherence unless they are chosen carefully. Materials like certain oxides, for example ceria and calcium oxide, which have intrinsically low nuclear-spin noise, help preserve the long spin coherence time of the 2D host. This finding provides a clear guideline on how to design high-performance 2D spin-qubit devices by selecting both a quiet host material and a quiet substrate.
To make such large-scale screening possible—and to accelerate future discovery—the authors also developed analytical models that capture the essential physics behind decoherence in 2D materials and heterostructures, inspired by the previous work of Tohoku University Assoc. Prof. Shun Kanai on 3D materials.
“These simple, structure-based formulas allow fast estimates of coherence times without running expensive simulations,” said Kanai, a co-author of the study.
With analytical models, the authors expanded their search to nearly 5,000 additional 2D materials from public databases, identifying over 500 new candidates with long predicted coherence times.
The broader message of the work is clear: the space of potentially useful 2D quantum materials is far richer than previously known. By combining high-throughput simulations, data-driven modeling, and physical insight, the study provides the community with a blueprint for systematically discovering next-generation qubit hosts in 2D systems. It also hints at an exciting direction: using artificial intelligence-inspired generative models similar to ChatGPT to design entirely new 2D materials optimized for quantum coherence.
“As quantum technologies move from the laboratory to practical devices, this kind of data-driven strategy will be essential,” said Galli. “It transforms what was once trial-and-error exploration into a rational search across a vast design space—bringing the goal of robust, scalable, quantum-enabled devices closer to reality.”
END
Expanding the search for quantum-ready 2D materials
2025-12-08
ELSE PRESS RELEASES FROM THIS DATE:
White paper on leadership opportunities for AI to increase employee value released by University of Phoenix College of Doctoral Studies
2025-12-08
University of Phoenix College of Doctoral Studies announces a new white paper, “Leadership Opportunities for Increasing Employee Value through Artificial Intelligence,” authored by Andrew C. Lawlor, PhD, and Pamayla E. Darbyshire, DHA, MSN/CNS, both Fellows at the Center for Educational and Instructional Technology Research (CEITR). The paper examines how leaders can use AI, especially generative AI, to address skills gaps, restore worker autonomy, and shift employees from repetitive tasks to higher-value activities.
The authors draw upon the University’s Career Optimism Index® study and other current research, ...
ASH 2025: New combination approach aims to make CAR T more durable in lymphoma
2025-12-08
MIAMI, FLORIDA (EMBARGOED UNTIL DEC. 8, 2025, AT 4:30 P.M. EST) – A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may sharply boost one-year progression-free survival for people with aggressive lymphoma.
In just a few years, treatment options for aggressive lymphoma have rapidly advanced. However, many patients show a consistent pattern: powerful new therapies act quickly but often fail to keep the lymphoma at bay permanently, says Jay Spiegel, M.D., a transplant and cellular therapy physician at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.
Spiegel ...
‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukemia
2025-12-08
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in helping children and adults fight a rare and aggressive form of blood cancer called T-cell acute lymphoblastic leukaemia (T-ALL).
The world-first gene therapy (BE-CAR7) uses base-edited immune cells to treat previously untreatable T-cell leukaemia and help patients achieve remission, offering new hope for families facing this aggressive cancer. Base-editing is an advanced version of CRISPR technology, that can precisely change single ...
How brain activity changes throughout the day
2025-12-08
An international team led by the University of Michigan has introduced new methods that reveal which regions of the brain were active throughout the day with single-cell resolution.
Using mouse models, the researchers developed an experimental protocol and a computational analysis to follow which neurons and networks within the brain were active at different times. Published in the journal PLOS Biology, the study provides new insights into brain signaling during sleep and wakefulness, which hints at the bigger questions and goals that motivated the work.
"We undertook this difficult study to understand fatigue," ...
Australian scientists reveal new genetic risk for severe macular degeneration
2025-12-08
Australian researchers have for the first time pinpointed specific genetic changes that increase the risk of severe, sight-threatening forms of age-related macular degeneration (AMD).
A new study, published today in Nature Communications, reveals the specific genetic factors linked to the presence of reticular pseudodrusen - deposits which drive vision loss and are found on the retina of up to 60 per cent of people with advanced AMD.
The research, led by the Centre for Eye Research Australia, WEHI and the University of Melbourne, offers a promising new target for treatments aimed at the most severe ...
GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk
2025-12-08
Embargoed for release until 5:00 p.m. ET on Monday 8 December 2025
Follow @Annalsofim on X, Facebook, Instagram, Bluesky, and Linkedin
Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of information. This information is under strict embargo and by taking it into possession, media representatives are committing to the terms of the embargo not only on their own behalf, but also on behalf of the organization ...
Precision immunotherapy to improve sepsis outcomes
2025-12-08
About The Study: Among patients with sepsis, precision immunotherapy targeting macrophage activation–like syndrome and sepsis-induced immunoparalysis improved organ dysfunction by day 9 compared with placebo.
Corresponding Author: To contact the corresponding author, Evangelos J. Giamarellos-Bourboulis, MD, PhD, email egiamarel@med.uoa.gr.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.24175)
Editor’s Note: Please see the article for additional information, including other ...
Insilico Medicine unveils winter edition of Pharma.AI, accelerating the path to pharmaceutical superintelligence
2025-12-08
The topics of human-level artificial general intelligence (AGI) and artificial superintelligence (ASI) have captivated researchers for decades. Interest has surged with the rapid progress and deployment of large language models (LLMs), which now handle tasks such as coding, scientific explanation, creative writing, and multimodal reasoning. “Solve AI and it will solve everything” remains a popular, if contested, credo—driving large-scale investment, shaping public narratives, and motivating optimism about transformative advances.
Applying this vision to the healthcare and pharmaceutical industries, ...
Study finds most people trust doctors more than AI but see its potential for cancer diagnosis
2025-12-08
FOR IMMEDIATE RELEASE
EMBARGOED UNTIL DECEMBER 8, 2025
Study Finds Most People Trust Doctors More than AI But See Its Potential for Cancer Diagnosis
Nationally representative surveys measure public attitudes toward AI in healthcare
Washington, D.C., December 8, 2025– New research on public attitudes toward AI indicates that most people are reluctant to let ChatGPT and other AI tools diagnose their health condition, but see promise in technologies that use AI to help diagnose cancer. These and other results of two nationally representative surveys will be presented at the ...
School reopening during COVID-19 pandemic associated with improvement in children’s mental health
2025-12-08
Embargoed for release: Monday, December 8, 2025, 4:00 PM ET
Key points:
Children whose schools reopened during the COVID-19 pandemic had significantly decreased mental health diagnoses relative to children whose schools remained closed, according to a new study of schools across California. This included fewer diagnoses of depression, anxiety, and ADHD. Girls’ mental health benefited the most.
Mental health care spending decreased by up to 11% by the ninth month after a school’s reopening.
The study is among the largest and most data-rich examinations of how school closures impacted ...